Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
I-Sep Logo
I-Sep Growth Score
33
CB Rank
133630
Heat Score
72
Auto-transfusion specialist through innovative technology for the separation of blood components.
Founded
obfuscation
PrivateVenture - Series Unknown Nantes, Pays de la Loire, France11-50 i-sep.com/
Biotechnology
Overview

I-Sep
Total Funding
obfuscation
Growth Score
33
Heat Score
72

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score33
-1 pts
in past quarter
Heat Score 72
5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About I-Sep

CB Rank
133630
Auto-transfusion specialist through innovative technology for the separation of blood components.
Founded
obfuscation
PrivateVenture - Series Unknown Nantes, Pays de la Loire, France11-50 i-sep.com/
Biotechnology

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name I-SEP SAS
Also Known As Innovative Separation
Operating Status Active
Company Type For Profit
Founders  Bertrand Chastenet, Francis Gadrat, Sylvain Picot
About the Company

i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management.

i-SEP has developed a completely innovative technology for the separation of blood components.

Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during

hemorrhagic surgical procedures.

i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

same™ Autotransfusion System
An intraoperative autotransfusion system that recovers and processes both red blood cells and platelets from a patient's blood during hemorrhagic surgeries.
Autotransfusion Treatment Set
A consumable kit used with the autotransfusion system to process and prepare the patient's blood for retransfusion during surgery.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown
obfuscation
Venture Round - I-Sep Logo
Venture Round - I-Sep
1
obfuscation
GO CAPITALVenture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
GO CAPITAL Logo
GO CAPITAL
Yes
Venture Round - I-Sep Logo
Venture Round - I-Sep
—
GO CAPITAL Logo
GO CAPITAL
Yes
Venture Round - I-Sep Logo
Venture Round - I-Sep
—
GO CAPITAL Logo
GO CAPITAL
Yes
Venture Round - I-Sep Logo
Venture Round - I-Sep
—
GO CAPITAL Logo
GO CAPITAL
Yes
Venture Round - I-Sep Logo
Venture Round - I-Sep
—
GO CAPITAL Logo
GO CAPITAL
Yes
Venture Round - I-Sep Logo
Venture Round - I-Sep
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Contacts 11

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

496

IT Spend

$225.1KThis year, I-Sep is projected to spend $225.1K on IT, according to Aberdeen.

Active Website Tech Count

9I-Sep is actively using 9 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, SPF, and  Facebook Sharer.

Total IP

20The intellectual property of I-Sep includes 11 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, I-Sep has registered 9 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is I-Sep's headquarters? I-Sep is located in Nantes, Pays de la Loire, France.Who invested in I-Sep? I-Sep is funded by GO CAPITAL.When was the last funding round for I-Sep? I-Sep closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are I-Sep's competitors? Alternatives and possible competitors to I-Sep may include Medtronic, Getinge, and  LivaNova.How much funding has I-Sep raised to date? I-Sep has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|